Citi Pharma Limited (PSX: CPHL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
34.25
-0.29 (-0.84%)
At close: Sep 9, 2024
72.11%
Market Cap 7.82B
Revenue (ttm) 13.07B
Net Income (ttm) 805.98M
Shares Out 228.46M
EPS (ttm) 3.53
PE Ratio 9.70
Forward PE 9.01
Dividend 2.50 (7.24%)
Ex-Dividend Date n/a
Volume 1,570,416
Open 34.90
Previous Close 34.54
Day's Range 34.10 - 35.15
52-Week Range 19.70 - 35.98
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Oct 4, 2024

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. The company was founded in 1990 and is headquartered in Lahore, Pakistan. [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1990
Employees 594
Stock Exchange Pakistan Stock Exchange
Ticker Symbol CPHL
Full Company Profile

Financial Performance

In 2023, Citi Pharma's revenue was 12.40 billion, an increase of 26.76% compared to the previous year's 9.78 billion. Earnings were 657.98 million, an increase of 0.66%.

Financial Statements

News

There is no news available yet.